Doctors may be cautious in recommending CBD due to the lack of extensive, long-term clinical trials and regulation inconsistencies. While there is growing research on CBD's benefits, the medical community generally awaits more comprehensive, standardized studies to fully understand its effects, dosing, and potential interactions with other medications. Additionally, the CBD market varies in quality and potency, raising concerns about product reliability. As medical understanding and regulatory frameworks evolve, we are confident doctors will become more comfortable incorporating CBD into treatment plans.